Mechanistically, in prostate cancer, the stimulator of the IFN genes (STING) pathway has been linked to the recruitment and activation of interferon-related genes in vitro, increasing sensitivity to the immune checkpoint inhibitor PD-L1 in DNA repair-deficient tumors [115,116,117,118]. Here, CD274 is linked to Familial prostate cancer.